HAEMOSTASIS REASEARCH UNIT
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

  • Home
  • Services
    • Validation Services
    • Accreditation Services
    • Product Development
    • PT/EQA program
    • Training services
    • Online Ordering
  • about us
  • Further information
    • Regulation updates
    • Case Studies
    • Testimonials
    • Blog
    • Terms and Conditions
    • Privacy Policy
  • More
    • Home
    • Services
      • Validation Services
      • Accreditation Services
      • Product Development
      • PT/EQA program
      • Training services
      • Online Ordering
    • about us
    • Further information
      • Regulation updates
      • Case Studies
      • Testimonials
      • Blog
      • Terms and Conditions
      • Privacy Policy
HAEMOSTASIS REASEARCH UNIT

Signed in as:

filler@godaddy.com

  • Home
  • Services
    • Validation Services
    • Accreditation Services
    • Product Development
    • PT/EQA program
    • Training services
    • Online Ordering
  • about us
  • Further information
    • Regulation updates
    • Case Studies
    • Testimonials
    • Blog
    • Terms and Conditions
    • Privacy Policy

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

Welcome to the Implementation and Validation team

Transitional Validations

Phase1. Device Feasibility studies

We have a range sample types  for clinical feasibility studies using prospective and retrospect study models to identify intended use or widen assay utility.

Phase 2. Instrument Optimisation

Improve performance with validations designed to detect assay limitations, find solutions, improve sensitivity  and specificity  on chosen disease states.  

Phase 3. Assay Validation

Our team can undertake the validations of all haemostasis testing including research only assays.

Phase 4. Adjusting formulation

Identifying interferences and adjusting protocols to improve specific and sensitivity  

Innovative solutions are transforming diagnostics in the medical field, ensuring accuracy and compliance like never before. Embrace the future of healthcare with our transitional validations  designed to enhance laboratory efficiency and patient outcomes.

Contact us

Types of Evaluations

User define Evaluations

 Method validation / verification is undertaken against a defined protocol / study plan, pre-approved & tailored to be stage appropriate for the development by the customer.


 Our team undertake  the entire  validation process and publish in reputable journals  to showcase your device/assay's performance and specifications as required. 

Get a quote

Performance Evaluation (PQ)

 

We undertake a systematic approach to investigations  that begins with pre-defined objectives based on extensive clinical input,  sound science and quality risk management. Investigations provided:

  1. Reproducibility & Accuracy
  2. Analytical Specificity    
  3. Identify Interferences; i.e.  concurrent drugs
  4. Est. Normal range  
  5. Linearity analysis 
  6. Method Comparison 
  7. Standard  operating manual construct
  8. Validation document  written up for clinical sign off


 

Get a quote

Comparative Testing

Use one of our collaborating laboratories for method specific  comparison using same batch of materials

(i.e. samples are analysed by the receiving laboratory in accordance with the test method, and the results are compared with the results obtained by the originating site for the same batches.

The results obtained from both sites are demonstrated to be comparable, against pre-defined acceptance criteria).

Get a quote

Device Optimisation

 Improve performance with validations designed detect assay limitations, find solutions, improve sensitivity and specificity on chosen disease states.   

Get a quote

Evaluation across different sites

Multisite evaluations using a range of platforms to examine variability and procedural non conformities.

Get a quote

Clinical Evaluation

Our Service evaluation are clinically lead.

 We perform retrospective and or prospective  studies and have access to a wide range of samples and pathologies.

Get a quote

Validation centre

Install your instrument at our London Research site

From early-stage R&D to post-market surveillance, we deliver end-to-end testing solutions and performance evaluations across analytical biomedical testing platforms. 

Contact us

Related Areas of Standard

ISO 13485: 2016

NCCLS document EP9-A2

NCCLS document EP9-A2

  

7.0 Product realisation

7.3 Design and development

7.3.2 Design and development planning

Learn more

NCCLS document EP9-A2

NCCLS document EP9-A2

NCCLS document EP9-A2

 Method Comparison and Bias Estimation Using Patient Samples 

Learn more

ISO 15189, 2022

NCCLS document EP9-A2

ISO 15189, 2022

 7.3.3 Requirements for Quality and Compliance and manufacturing process”

Learn more

Guide for individual evaluation types and Part number

Full Assay validation-Part Number 180101

Bringing inhouse products to clinical use using relevant essential requirements of the IVD Directive 98/79 EC or Regulation 2017/746

Phase 1: Feasibility

Minimum data point analyzed: 100 samples

  1.  Clinical application research
  2.  Establishment  of intended use
  3.  Scope utility: comparison to other methods 
  4.  Validate Specificity claims  
  5.  Initial Quality program design
  6. Product application sheet construct 
  7. Feasibility data publication
  8. Validation action plan write up

Phase 2: Design qualification

Minimum data point analyzed: 100 samples

  1. Assay optimization plan 
  2. Establishment of best practice. Pre-analytical, sample types, sample stability, sample rejection criteria 
  3. Instrument maintenance / critical operational elements identification 
  4. Identify reagent best practice; reagent source, stabilities 
  5. Finalize Quality program/SOP 
  6.  Estimation of margin of error (MU)

Phase 3: Performance Qualification

Minimum data point analyzed: 200 samples

Clinical verification 

  1. Reproducibility & Accuracy
  2. Analytical Specificity    
  3. Identify Interferences; i.e.  concurrent drugs
  4. Establish Normal range  
  5. Linearity analysis 
  6. Method Comparison 
  7. Standard  operating manual construct
  8. Validation document  written up for clinical sign off


bite size validations

Method Comparison and Bias Estimation- initial analytical evaluation

Part number:1503

 Evaluate the test method over the clinically meaningful range, i.e., where medical decisions are made.  Analyze at least 40 samples as CLSI EP9-A2 recommendations

Method Comparison and Bias Estimation- extended clinical evaluation

Part number:1504

 Evaluate the test method using 100  clinically meaningful samples against reference methods and perform data analysis and clinical correlation

Robustness

Part number:1505

Evaluate method stability under varied conditions. Includes solution stability and system suitability parameters. 

Minimum of 120 data points used in this study.



Validation support

User requirements and verification plan

Part number:1506

Design verification documentation to confirm that the design output meets the design input requirements.   


Sample requirements

Part number:1507

Identifying sample requirements as per verification plan and sourcing them for the study.


Prices are dependent of study size and complexity of requirements

  • Regulation updates
  • Terms and Conditions
  • Privacy Policy

ISOChecks.co.uk

Copyright © 2025 ISOChecks.co.uk - All Rights Reserved.

Powered by